$ACMR

Wang David H sold $73K of ACMR

Wang David H (See Remarks) sold 826 shares of ACM Research, Inc. (ACMR) at $87.91 on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang David H
Published Jun 5, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACMR
Neutral
high confidence
Mentioned
$ACMR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRNeutralLow
01

Why it matters

Because the sale is explicitly under a pre-arranged Rule 10b5-1 plan, it generally does not indicate new, non-public information; it mainly updates insider activity records.

02

Market read

Insider activity update for ACMR; no fundamental catalyst is provided.

03

What to watch

The sale size (826 shares) is small relative to typical liquidity/float, and the 10b5-1 structure reduces interpretability.

Relevance 3/10Novelty 2/10Timing: Filed after-hours (2026-06-05) for a sale executed 2026-06-04

Background

The article is an SEC Form 4 insider transaction disclosure (open-market sale) for ACM Research, Inc.

Company-level read

Ticker impact

$ACMRNeutralHigh confidence
Context

Officer/director/10% owner Wang David H sold 826 shares of ACM Research on a Rule 10b5-1 plan at $87.91.

Expected impact

Likely minimal near-term impact; any effect is more about sentiment than new business information.

Evidence & confidence

The filing is a routine Form 4 disclosure with an explicitly pre-arranged 10b5-1 plan and no accompanying corporate event.

Market effects

No meaningful sector read-through from a single small insider sale disclosure.

None.

None.

Counterpoint

Even 10b5-1 sales can coincide with private views; traders may still watch for follow-on selling or clustering of insider trades.

Key entities

  • ACM Research, Inc.

    Subject of the Form 4 insider sale by officer/director/10% owner Wang David H.

  • Wang David H

    Officer, director, and 10% owner who executed an open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACMRMed

AI Sovereignty Becomes a New National Security Battleground: Morgan Stanley Names SpaceX and 4 Other Beneficiary Stocks, with Upside Potential Topping 100% — BigGo Finance

Morgan Stanley identifies SpaceX, ACM Research, Amkor Technology, Alibaba, and KLA as key beneficiaries of the AI sovereignty trend. The bank assigns price targets with upside potential ranging from 21% to 105%, highlighting the strategic importance of AI infrastructure for national security and economic competitiveness.

$ACMRMed

ACM Research (NASDAQ: ACMR) unit’s orders surge past 100% with 42–48% margin outlook

ACM Research (Shanghai) reported a 105% year-over-year increase in new orders for the first half of 2026, with growth across electroplating, cleaning, and advanced packaging equipment. The company expects gross margins to remain between 42% and 48%. Significant orders include panel-level electroplating systems for delivery in 2026 and 2027. ACM Shanghai also highlighted rapid growth in mature-node semiconductor manufacturing and AI-related equipment demand.

$ACMRMedAI 9/10

ACM Research (ACMR) Q2 2026 Earnings Call Transcript

ACM Research (ACMR) reported Q2 2026 revenue of $292.9M, up 36% year over year, with non-GAAP diluted EPS of $0.61. Non-GAAP gross margin was 46.0%. The company raised 2026 revenue guidance to $1.125B-$1.175B and said first-half orders rose 105%. Net cash was $1.0B.